Combination treatment with vibegron and solifenacin for refractory non-monosymptomatic enuresis

Pediatr Int. 2023 Jan-Dec;65(1):e15651. doi: 10.1111/ped.15651.

Authors

Yusuke Gonda^{1

2}, Shuichiro Fujinaga¹, Hiroki Miyano^{1

3}

Affiliations

¹ Division of Nephrology, Saitama Children's Medical Center, Saitama, Japan.
² Department of Pediatrics, Juntendo University Urayasu Hospital, Chiba, Japan.
³ Department of Pediatrics, Juntendo University Nerima Hospital, Tokyo, Japan.

PMID: 37804057
DOI: 10.1111/ped.15651

No abstract available

Publication types

Letter

MeSH terms

Deamino Arginine Vasopressin
Humans
Nocturnal Enuresis* / drug therapy
Pyrimidinones
Solifenacin Succinate / therapeutic use
Urinary Incontinence*

Substances

Solifenacin Succinate
N-(4-((5-(hydroxy(phenyl)methyl)pyrrolidin-2-yl)methyl)phenyl)-4-oxo-4,6,7,8-tetrahydropyrrolo(1,2-a)pyrimidine-6-carboxamide
Pyrimidinones
Deamino Arginine Vasopressin